Athira Pharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 02/14/2025 | 5.40 M | $3.17 M | 0.00% | 14.03% |
| BML CAPITAL MANAGEMENT, LLC | 02/07/2025 | 2.78 M | $1.63 M | 100.00% | 7.21% |
| VANGUARD GROUP INC | 02/11/2025 | 1.56 M | $913,754 | -3.50% | 4.04% |
| SIMPLIFY ASSET MANAGEMENT INC. | 02/11/2025 | 1.49 M | $875,821 | 0.00% | 3.88% |
| PROPEL BIO MANAGEMENT, LLC | 02/14/2025 | 1.49 M | $875,821 | 0.00% | 3.88% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 600,000 | $352,020 | 0.00% | 1.56% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 458,765 | $269,157 | -14.34% | 1.19% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 434,492 | $254,000 | -8.82% | 1.13% |
| PATHSTONE HOLDINGS, LLC | 02/14/2025 | 372,196 | $218,367 | -24.37% | 0.97% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 350,007 | $205,349 | 455.28% | 0.91% |
| BRISTLECONE ADVISORS, LLC | 01/29/2025 | 337,506 | $198,015 | 0.00% | 0.88% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 320,844 | $188,295 | 0.00% | 0.83% |
| GSA CAPITAL PARTNERS LLP | 02/07/2025 | 296,556 | $174,000 | -25.32% | 0.77% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 253,300 | $148,611 | -24.97% | 0.66% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 207,300 | $121,623 | -54.22% | 0.54% |
| ROYAL BANK OF CANADA | 02/14/2025 | 183,018 | $107,000 | 2,094.20% | 0.48% |
| LAIRD NORTON TRUST COMPANY, LLC | 02/14/2025 | 127,309 | $74,692 | -13.58% | 0.33% |
| STATE STREET CORP | 02/14/2025 | 107,381 | $63,000 | -0.37% | 0.28% |
| UBS GROUP AG | 02/14/2025 | 86,976 | $51,054 | 635.34% | 0.23% |
| ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 81,300 | $36,585 | -1.28% | 0.21% |
| CLARIUS GROUP, LLC | 01/16/2025 | 53,551 | $31,418 | 0.00% | 0.14% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 49,283 | $28,914 | 168.56% | 0.13% |
| INVST, LLC | 02/19/2025 | 45,000 | $26,402 | 0.00% | 0.12% |
| HRT FINANCIAL LP | 02/14/2025 | 42,749 | $25,000 | 100.00% | 0.11% |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 02/10/2025 | 38,983 | $22,871 | 100.00% | 0.10% |
| EASTERLY INVESTMENT PARTNERS LLC | 02/12/2025 | 33,500 | $19,654 | 0.00% | 0.09% |
| INTEGRITY FINANCIAL CORP /WA | 02/13/2025 | 32,786 | $19,236 | 0.00% | 0.09% |
| BRIGHTON JONES LLC | 03/04/2025 | 32,200 | $18,892 | 0.00% | 0.08% |
| SIMON QUICK ADVISORS, LLC | 01/17/2025 | 20,538 | $12,050 | 0.00% | 0.05% |
| JOURNEY STRATEGIC WEALTH LLC | 01/24/2025 | 20,538 | $12,050 | 0.00% | 0.05% |
| BLAIR WILLIAM & CO/IL | 02/12/2025 | 20,000 | $11,734 | 0.00% | 0.05% |
| XTX TOPCO LTD | 02/13/2025 | 17,688 | $10,378 | 100.00% | 0.05% |
| ENGINEERS GATE MANAGER LP | 02/14/2025 | 16,458 | $9,656 | -0.06% | 0.04% |
| LARSON FINANCIAL GROUP LLC | 02/07/2025 | 15,000 | $8,801 | 0.00% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 13,392 | $7,861 | 161.82% | 0.03% |
| HIGHTOWER ADVISORS, LLC | 02/07/2025 | 12,697 | $7,449 | 1.84% | 0.03% |
| SHAY CAPITAL LLC | 02/14/2025 | 11,800 | $6,923 | 100.00% | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 11,000 | $6,454 | 0.00% | 0.03% |
| SARGENT INVESTMENT GROUP, LLC | 01/27/2025 | 10,918 | $5,799 | -44.06% | 0.03% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 10,085 | $5,917 | -0.33% | 0.03% |
| LINDBROOK CAPITAL, LLC | 02/06/2025 | 8,920 | $5,233 | 0.00% | 0.02% |
| SIMPLEX TRADING, LLC | 02/11/2025 | 2,184 | $1,000 | -92.56% | 0.01% |
| AMERICAN CAPITAL ADVISORY, LLC | 01/28/2025 | 2,000 | $1,174 | 0.00% | 0.01% |
| ROTHSCHILD INVESTMENT LLC | 02/04/2025 | 1,500 | $880 | -88.37% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 1,361 | $798 | 100.00% | 0.00% |
| FEDERATED HERMES, INC. | 02/13/2025 | 1,014 | $595 | -93.27% | 0.00% |
| MCILRATH & ECK, LLC | 02/18/2025 | 825 | $484 | 0.00% | 0.00% |
| US BANCORP \DE\ | 02/05/2025 | 815 | $478 | 0.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 02/06/2025 | 334 | $196 | 0.00% | 0.00% |
| 02/06/2025 | 154 | $90 | 100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Athira Pharma, Inc. institutional Ownership - FAQ's
During the previous two years, 78 institutional investors and hedge funds held shares of Athira Pharma, Inc.. The most heavily invested institutionals were:
PERCEPTIVE ADVISORS LLC: 5.4 M
BML Capital Management, LLC: 2.78 M
VANGUARD GROUP INC: 1.56 M
Simplify Asset Management Inc.: 1.49 M
Propel Bio Management, LLC: 1.49 M
TANG CAPITAL MANAGEMENT LLC: 600,000
46.58% of Athira Pharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 19.50 M shares in the last 24 months. This purchase volume represents approximately $11.12 M in transactions.